Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
2.200
-0.060 (-2.65%)
At close: Dec 19, 2025, 4:00 PM EST
2.245
+0.045 (2.03%)
After-hours: Dec 19, 2025, 7:41 PM EST
Fractyl Health Employees
Fractyl Health had 107 employees as of December 31, 2024. The number of employees increased by 5 or 4.90% compared to the previous year.
Employees
107
Change (1Y)
5
Growth (1Y)
4.90%
Revenue / Employee
$28
Profits / Employee
-$1,142,028
Market Cap
301.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107 | 5 | 4.90% |
| Dec 31, 2023 | 102 | 19 | 22.89% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GUTS News
- 5 days ago - Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones - GlobeNewsWire
- 19 days ago - Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - GlobeNewsWire
- 20 days ago - Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Fractyl Health, Inc. (GUTS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027 - GlobeNewsWire
- 6 weeks ago - Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025 - GlobeNewsWire
- 2 months ago - Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity - GlobeNewsWire
- 2 months ago - Fractyl Health: Best-Case Results; Financing Dilutes But Removes Overhang - Seeking Alpha